Infinimol AI is a startup focused on revolutionizing drug discovery through an advanced AI-driven platform. Their integrated solution offers virtual screening, lead optimization, and semantic search capabilities, enabling researchers to efficiently identify and develop new drug candidates while reducing costs and time in the early stages of research.
PharmAI specializes in drug discovery through advanced chemoinformatics and structure analysis. Their offerings include focused library screening, scaffold diversification, and off-target identification, utilizing a knowledge-based approach and AI-driven technology to optimize compound libraries and enhance the precision of drug candidate identification. Their goal is to accelerate the drug discovery process while reducing costs and improving accuracy.